The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas

  1. Dash, S.
  2. Hanson, S.
  3. King, B.
  4. Nyswaner, K.
  5. Foss, K.
  6. Tesi, N.
  7. Harvey, M.J.B.
  8. Navarro-Marchal, S.A.
  9. Woods, A.
  10. Poradosu, E.
  11. Unciti-Broceta, A.
  12. Carragher, N.O.
  13. Brognard, J.
Zeitschrift:
Journal of Biological Chemistry

ISSN: 1083-351X 0021-9258

Datum der Publikation: 2024

Ausgabe: 300

Nummer: 9

Art: Artikel

DOI: 10.1016/J.JBC.2024.107615 GOOGLE SCHOLAR lock_openOpen Access editor